Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 Jun;37:1479–1483.

Transrectal Ultrasound of Prostatic Carcinoma

A new way to evaluate benign and malignant conditions

Daniel J Murray, Peter L Cooperberg, S Larry Goldenberg, Ants Toi
PMCID: PMC2145402  PMID: 21229044

Abstract

The purpose of this paper is to review the indications for transrectal ultrasound; to briefly describe the sonographic technique; to describe the sonographic findings of prostatic carcinoma; to review the indications for transrectal sonographic-guided biopsy; and to discuss the controversles of routine screening and staging.

Full text

PDF
1479

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dyke C. H., Toi A., Sweet J. M. Value of random US-guided transrectal prostate biopsy. Radiology. 1990 Aug;176(2):345–349. doi: 10.1148/radiology.176.2.2195588. [DOI] [PubMed] [Google Scholar]
  2. Guinan P., Bhatti R., Ray P. An evaluation of prostate specific antigen in prostatic cancer. J Urol. 1987 Apr;137(4):686–689. doi: 10.1016/s0022-5347(17)44175-9. [DOI] [PubMed] [Google Scholar]
  3. Hamper U. M., Sheth S., Walsh P. C., Holtz P. M., Epstein J. I. Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundle. AJR Am J Roentgenol. 1990 Nov;155(5):1015–1019. doi: 10.2214/ajr.155.5.2120928. [DOI] [PubMed] [Google Scholar]
  4. Lee F., Littrup P. J., Torp-Pedersen S. T., Mettlin C., McHugh T. A., Gray J. M., Kumasaka G. H., McLeary R. D. Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology. 1988 Aug;168(2):389–394. doi: 10.1148/radiology.168.2.3293108. [DOI] [PubMed] [Google Scholar]
  5. McNeal J. E. Regional morphology and pathology of the prostate. Am J Clin Pathol. 1968 Mar;49(3):347–357. doi: 10.1093/ajcp/49.3.347. [DOI] [PubMed] [Google Scholar]
  6. Platt J. F., Bree R. L., Schwab R. E. The accuracy of CT in the staging of carcinoma of the prostate. AJR Am J Roentgenol. 1987 Aug;149(2):315–318. doi: 10.2214/ajr.149.2.315. [DOI] [PubMed] [Google Scholar]
  7. Rifkin M. D., Zerhouni E. A., Gatsonis C. A., Quint L. E., Paushter D. M., Epstein J. I., Hamper U., Walsh P. C., McNeil B. J. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med. 1990 Sep 6;323(10):621–626. doi: 10.1056/NEJM199009063231001. [DOI] [PubMed] [Google Scholar]
  8. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  9. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES